ANVISA registration 10259610186Active

ANTICYTOPLASMIC ANTIBODY

Name: ANTICYTOPLASMIC ANTIBODY — ANVISA registration 10259610186
Creator: AESKU DIAGNOSTICS
Keywords: ANTICYTOPLASMIC ANTIBODY, ANTICORPO ANTICITOPLASMÁTICO, AESKULISA PR3 sensitive, 10259610186, Risk Class II, ANVISA registration

ANVISA Registration Number: 10259610186MEDIVAX INDÚSTRIA E COMÉRCIO LTDAAESKU DIAGNOSTICSRisk Class II

Verified

Device names

Technical name: ANTICYTOPLASMIC ANTIBODY
Commercial name: AESKULISA PR3 sensitive
Risk class: Class II

Registration details

Registration Number: 10259610186
Process Number: 25351590041201782
CNPJ: 68814961000173

Company information

Registration Holder: MEDIVAX INDÚSTRIA E COMÉRCIO LTDA
Manufacturer: AESKU DIAGNOSTICS
Manufacturing Country: Germany

Dates and status

Publication Date: Jan 08, 2018
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for ANTICYTOPLASMIC ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610186 and manufactured by AESKU DIAGNOSTICS. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.